


Healthcare News Roundup: Oncology
HSMN NewsFeed - 10 Sep 2013
Metamark Announces Positive Results of ProMark(TM) Prostate Cancer Clinical Validation Study
Metamark Announces Positive Results of ProMark(TM) Prostate Cancer Clinical Validation Study
HSMN NewsFeed - 6 Sep 2013
Oncothyreon Announces Appointment of Ted W. Love, M.D. to Board of Directors
Oncothyreon Announces Appointment of Ted W. Love, M.D. to Board of Directors
HSMN NewsFeed - 5 Sep 2013
GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
HSMN NewsFeed - 28 Aug 2013
First-ever Gamma Knife in Alaska Offers New Options for Treating Brain Cancer and Other Disorders
First-ever Gamma Knife in Alaska Offers New Options for Treating Brain Cancer and Other Disorders
HSMN NewsFeed - 26 Aug 2013
GeneDx Introduces Advanced Genetic Test Panels for Inherited Cancer Including Breast and Colon Cancer
GeneDx Introduces Advanced Genetic Test Panels for Inherited Cancer Including Breast and Colon Cancer
HSMN NewsFeed - 23 Aug 2013
RaySearch Laboratories: Provision Center for Proton Therapy Selects RayStation(R)
RaySearch Laboratories: Provision Center for Proton Therapy Selects RayStation(R)
HSMN NewsFeed - 21 Aug 2013
Elekta's Versa HD System Now Features Automated Breath Hold Gating for Improved Breast and Lung Radiotherapy
Elekta's Versa HD System Now Features Automated Breath Hold Gating for Improved Breast and Lung Radiotherapy
HSMN NewsFeed - 19 Aug 2013
Market Access Granted in France for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI(R) (pixantrone)
Market Access Granted in France for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI(R) (pixantrone)
HSMN NewsFeed - 16 Aug 2013
Accuray will showcase its CyberKnife(R) and TomoTherapy(R) Systems at CHINA-HOSPEQ 2013
Accuray will showcase its CyberKnife(R) and TomoTherapy(R) Systems at CHINA-HOSPEQ 2013
HSMN NewsFeed - 8 Aug 2013
FDA Grants Orphan Drug Status To Eisai's Investigational Compound (E7777) For Cutaneous T-Cell Lymphoma
FDA Grants Orphan Drug Status To Eisai's Investigational Compound (E7777) For Cutaneous T-Cell Lymphoma
HSMN NewsFeed - 7 Aug 2013
Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Brachytherapy Seeds
Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Brachytherapy Seeds
HSMN NewsFeed - 1 Aug 2013
Elekta to Exhibit New Versa HD Radiotherapy System at Annual Radiation Physics Conference
Elekta to Exhibit New Versa HD Radiotherapy System at Annual Radiation Physics Conference
HSMN NewsFeed - 31 Jul 2013
Oncos Therapeutics Granted Orphan Drug Designation for CGTG-102 in Soft Tissue Sarcoma (STS) by FDA and EMA
Oncos Therapeutics Granted Orphan Drug Designation for CGTG-102 in Soft Tissue Sarcoma (STS) by FDA and EMA
HSMN NewsFeed - 31 Jul 2013
Astellas Appoints New Senior Vice President of Global Oncology Development
Astellas Appoints New Senior Vice President of Global Oncology Development
HSMN NewsFeed - 24 Jul 2013
Celator(R) Pharmaceuticals Appoints Michael R. Dougherty to Board of Directors
Celator(R) Pharmaceuticals Appoints Michael R. Dougherty to Board of Directors
HSMN NewsFeed - 24 Jul 2013
PDL BioPharma Appoints David Montez as Controller and Chief Accounting Officer
PDL BioPharma Appoints David Montez as Controller and Chief Accounting Officer
HSMN NewsFeed - 24 Jul 2013
Verastem Receives Orphan Drug Designation from the U.S. FDA for Defactinib in Mesothelioma
Verastem Receives Orphan Drug Designation from the U.S. FDA for Defactinib in Mesothelioma
